NCT02700828View on ClinicalTrials.gov

Hydrocortisone Treatment In Systemic Low Blood Pressure During Hypothermia in Asphyxiated Newborns

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

November 30, 2017

Study Completion Date

December 15, 2022

Conditions
Hypoxic-Ischemic EncephalopathyAsphyxia
Interventions
DRUG

Hydrocortisone

4 \* 0,5 mg/kg /24 hours (in every 6 hours) iv., during hypothermia treatment (max. 72 hours)

DRUG

Placebo

4 \* 2 ml isotonic sodium chloride solution /24 hours (in every 6 hours) iv., during hypothermia treatment (max. 72 hours)

Trial Locations (1)

1083

Semmelweis University, 1st Department of Paediatrics, Budapest

All Listed Sponsors
lead

Semmelweis University

OTHER

NCT02700828 - Hydrocortisone Treatment In Systemic Low Blood Pressure During Hypothermia in Asphyxiated Newborns | Biotech Hunter | Biotech Hunter